Table 3.
Authors | Subjects | Antimicrobial | Clinical cure rate | Significant difference |
---|---|---|---|---|
Muller (1987)17 | Cholecystitis | ABPC+TOB | 11/13 (85%) | |
Piperacillin | 18/19 (95%) | NS | ||
Cefoperazone | 19/20 (95%) | NS | ||
Chacon (1990)18 | Cholecystitis + | Pefloxacin | 49/50 (98%) | NS |
cholangitis | ABPC+GM | 45/47(95.7%) | ||
Thompson (1993)19 | Cholecystitis + | Cefepime | 78/80 (97.5%) | NS |
cholangitis | Mezlocillin+GM | 40/40 (100%) |
ABPC, ampicillin; TOB, tobramycin; GM, gentamicin